Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiomyopathy resulting from age-related failure of homoeostatic mechanisms in wild-type ATTR (wtATTR-CM) or destabilizing mutations in variant TTR (vATTR-CM). Atrial fibrillation (AF) is very prevalent in ATTR-CM, affecting up to 70% of patients.
Total atrial conduction time predicts new-onset atrial fibrillation in patients with transthyretin amyloid cardiomyopathy
Dal Passo, BeatricePrimo
;Arzenton, MatteoSecondo
;Cantone, Anna;Fabbri, Gioele;Bonini, Jacopo;Guidi Colombi, Gabriele;Melpignano, Angelo;Marchini, Federico;Izzo, Carmen;Pavasini, Rita;Bertini, Matteo
;Campo, GianlucaPenultimo
;Serenelli, MatteoUltimo
2025
Abstract
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiomyopathy resulting from age-related failure of homoeostatic mechanisms in wild-type ATTR (wtATTR-CM) or destabilizing mutations in variant TTR (vATTR-CM). Atrial fibrillation (AF) is very prevalent in ATTR-CM, affecting up to 70% of patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dal Passo.pdf
accesso aperto
Descrizione: Full text editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
Creative commons
Dimensione
122.26 kB
Formato
Adobe PDF
|
122.26 kB | Adobe PDF | Visualizza/Apri |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
